New research has uncovered an essential mechanism coordinating the processes of cell division and adhesion within humans. This discovery has profound potential for advancing understanding of cell ...

MONTREAL--(BUSINESS WIRE)--Morphocell Technologies Inc. announces the development of an innovative, scalable method for generating cells that may enable future cell therapies for liver diseases and ...

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...

Researchers at New York University and the University of Chicago have developed artificial, fully synthetic cell-like structures that autonomously ingest, process, and push out material, recreating an ...

Most research labs can make cells that produce antibodies. The trick is making those antibodies in sufficient quantity and quality to use throughout clinical trials and for manufacturing scale-up.

Pluri, Inc. ('Pluri”, the 'Company”, 'we” or 'us”) (Nasdaq, TASE: PLUR), a leading biotechnology company leveraging its ...

With the FDA expecting to approve 10–20 Cell and Gene Therapies (CGTs) annually by 2025, it is evident that the field will continue to hold immense commercial and medical opportunities. To harness ...

TOKYO--(BUSINESS WIRE)--PHC Corporation Biomedical Division (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura, hereinafter referred to as "Biomedical Division") will showcase a prototype ...

CellVoyant, a U.K.-based startup, has launched an AI platform that allows scientists to predict the future health and ...

As people age, their immune system function declines. T cell populations become smaller and can't react to pathogens as ...